VX-765 Enhances Autophagy of Human Umbilical Cord Mesenchymal Stem Cells Against Stroke-induced Apoptosis and Inflammatory Responses Via AMPK/mTOR Signaling Pathway
Overview
Pharmacology
Authors
Affiliations
Introduction: To investigate the protective effect of VX-765 on human umbilical mesenchymal stem cells (HUMSCs) in stroke and its mechanism.
Materials And Methods: Mouse models of ischemic stroke were established using the distal middle cerebral artery occlusion (dMCAO) method. The dMCAO mice were accordingly transplanted with HUMSCs, VX-765-treated HUMSCs, or VX-765 + MHY185-treated HUMSCs. The HUMSCs were inserted with green fluorescent protein (GFP) for measurement of transplantation efficiency which was determined by immunofluorescence assay. Oxygen-glucose deprivation (OGD) was applied to mimic ischemic environment in vitro experiments, and the HUMSCs herein were transfected with AMPK inhibitor Compound C or autophagy inhibitor 3-MA. MTT assay was used to test the toxicity of VX-765. TUNEL staining and ELISA were applied to measure the levels of apoptosis and inflammatory cytokines (IL-1β, IL-6, and IL-10), respectively. The expressions of autophagy-associated proteins, AMPK, and mTOR were detected by Western blotting. TTC staining was applied to reveal the infarct lesions in the brain of dMCAO mice.
Results: The pro-inflammatory cytokines, TUNEL-positive cells, and p-mTOR were decreased while the anti-inflammatory cytokine, autophagy-related proteins, and p-AMPK were increased in HUMSCs treated with VX-765 under OGD condition. Different expression patterns were found with the above factors after transfection of 3-MA or Compound C. The pro-inflammatory cytokines, TUNEL-positive cells, and infarct sections were decreased while the anti-inflammatory cytokine and autophagy-related proteins were increased in dMCAO mice transplanted with VX-765-treated HUMSCs compared to those transplanted with HUMSCs only. The autophagy was inhibited while p-mTOR was up-regulated after transfection of MHY.
Conclusion: VX-765 protects HUMSCs against stroke-induced apoptosis and inflammatory responses by activating autophagy via the AMPK/mTOR signaling pathway in vivo and in vitro.
Research progress and challenges of stem cell therapy for ischemic stroke.
Cha Z, Qiao Y, Lu Q, Wang Q, Lu X, Zhou H Front Cell Dev Biol. 2024; 12:1410732.
PMID: 39040041 PMC: 11260720. DOI: 10.3389/fcell.2024.1410732.
Li R, Duan W, Feng T, Gu C, Zhang Q, Long J Chin Med. 2023; 18(1):117.
PMID: 37691119 PMC: 10494430. DOI: 10.1186/s13020-023-00831-8.
Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation.
Lockard G, Alayli A, Monsour M, Gordon J, Schimmel S, Elsayed B Int J Mol Sci. 2022; 23(24).
PMID: 36555094 PMC: 9779061. DOI: 10.3390/ijms232415453.
Contemplating IL-6, a double-edged sword cytokine: Which side to use for stroke pathology?.
Monsour M, Croci D, Agazzi S, Borlongan C CNS Neurosci Ther. 2022; 29(2):493-497.
PMID: 36478506 PMC: 9873516. DOI: 10.1111/cns.14041.
Wang J, Fu M, Xu D, Cao N, Li W, Tian Y Vet Sci. 2022; 9(11).
PMID: 36356092 PMC: 9692480. DOI: 10.3390/vetsci9110615.